GlassScriptPhysician profile
Sasha K Baker
NPI 1972943454
$495.53
in general payments reported to CMS, 2019-2025
13 companies · $58.43 in 2025
The $58.43 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $222 · 2020: $23.27 · 2021: $134 · 2022: $15.38 · 2024: $42.38 · 2025: $58.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $100.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $96.74 | 2020-2021 | |
| Cardiovascular Systems INC. | $83.44 | 2019 | |
| Exact Sciences Corporation | $80.48 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Pfizer INC. | $42.93 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $36.39 | 2019-2021 | |
| Lilly USA, LLC | $33.85 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $21.09 | 2019 | |
| Bausch Health US, LLC | $21.06 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.33 | 2024 | Synjardy, Jardiance |
| Currax Pharmaceuticals LLC | $15.68 | 2019 | |
| Glaxosmithkline, LLC. | $15.38 | 2022 | |
| Esperion Therapeutics, INC. | $15.01 | 2021 | |
| Allergan, INC. | $13.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sasha Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.